Putylone (also known as β-keto-1,3-benzodioxolyl-N-propyldioxybutanamine, bk-PBDB, and N-propylbutylone) is a stimulant and empathogen compound detected in 2023,[1] around the time of a ban on the related compound eutylone.

Putylone
Clinical data
ATC code
  • none
Legal status
Legal status
Identifiers
  • 1-(1,3-benzodioxol-5-yl)-2-(propylamino)butan-1-one
CAS Number
PubChem CID
ChemSpider
UNII
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC14H19NO3
Molar mass249.310 g·mol−1
3D model (JSmol)
  • CCCNC(CC)C(=O)C1=CC2=C(C=C1)OCO2
  • InChI=1S/C14H19NO3/c1-3-7-15-11(4-2)14(16)10-5-6-12-13(8-10)18-9-17-12/h5-6,8,11,15H,3-4,7,9H2,1-2H3 ☒N
  • Key:NRIHOTHAMAUSRO-UHFFFAOYSA-N ☒N
 ☒NcheckY (what is this?)  (verify)
edit

The specific legal status of putylone has not yet been addressed by any agency or government.

Putylone is likely considered illegal in jurisdictions where similar analogues or psychoactive substances bans are in place, such as in the US, UK, and Ireland.

See also

edit

References

edit
  1. ^ Dixon DI, Millea MF, Wilcock AT, Costello A, Ellison JR, Lord S, O'Brian KA, Mewis RE, Sutcliffe OB (September 2023). "Synthesis, characterisation and quantification of the new psychoactive substance 1-(1,3-benzodioxol-5-yl)-2-(propylamino)butan-1-one (bk-PBDB, putylone)". Forensic Chemistry. 35: 100523. doi:10.1016/j.forc.2023.100523. ISSN 2468-1709. S2CID 260833005.